| 000 | 01430 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513092306.0 | ||
| 264 | 0 | _c19960815 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0001-5792 | ||
| 024 | 7 |
_a10.1159/000203712 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNiitsu, N | |
| 245 | 0 | 0 |
_aEvaluation of cytosine arabinoside, carboplatin and etoposide chemotherapy in the treatment of relapsing and refractory non-Hodgkin's lymphoma. _h[electronic resource] |
| 260 |
_bActa haematologica _c1996 |
||
| 300 |
_a36-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aUmeda, M | |
| 773 | 0 |
_tActa haematologica _gvol. 96 _gno. 1 _gp. 36-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000203712 _zAvailable from publisher's website |
| 999 |
_c8675598 _d8675598 |
||